Garry Nicholson
Chairman at G1 THERAPEUTICS, INC.
Net worth: 55 542 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jack Bailey | M | 59 | 4 years | |
| Monica Thomas | F | - | 1 years | |
| Charles York | M | 47 | 3 years | |
| Judith Li | F | 40 |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | 6 years |
| Jeremy Bender | M | 52 | 4 years | |
| Sandra Ramos-Alves | F | - | 2 years | |
| Samuel Blackman | M | 55 | 6 years | |
| Adam Levy | M | - | 3 years | |
| Raphaël Rousseau | M | 55 | 1 years | |
| Ellen Feigal | M | 69 | 3 years | |
| Dan Becker | M | 49 | 5 years | |
| Jacks Lee | M | 60 | 2 years | |
| Alicia Secor | F | 62 | 3 years | |
| Norman Sharpless | M | 57 | 2 years | |
| Sona Saira Ramasastry | F | 48 | 3 years | |
| Michael Gladstone | M | 37 | 5 years | |
| John Houston | M | 64 | 4 years | |
| Terry Murdock | M | 64 | 7 years | |
| Glenn Muir | M | 65 | 9 years | |
| Carl June | M | 70 |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | - |
| Robert Langer | M | 75 |
XTuit Pharmaceuticals, Inc.
 XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology XTuit Pharmaceuticals, Inc. develops drugs for the treatment of cancer. The firm develops pharmaceutical products for use in the diagnosis and treatment of oncological, tumor and inflammatory diseases. The company was founded by Alan L. Crane, Rakesh Kumar Jain, Andrew Werk Cook, Edwin L. Steele, David H. Koch, Ronald Evans, Howard Hughes and Robert S. Langer, Jr. in 2011 and is headquartered in Waltham, MA. | 13 years |
| J. Garland | M | 55 | 3 years | |
| Sujay Kango | M | 60 |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | - |
| Natalie Holles | F | 51 | 3 years | |
| Shantanu Narayen | M | 60 | 11 years | |
| William C. Roberts | M | 54 | 3 years | |
| Anne Borgman | M | 56 | 3 years | |
| Cynthia Flowers | F | 64 | 6 years | |
| Jim Smith | M | 64 | 10 years | |
| Helen Hobbs | M | 71 | 13 years | |
| John Josey | M | 63 | 4 years | |
| Sophia Park | F | - | 2 years | |
| Davy Chiodin | M | - | - | |
| Mike Pregih | M | - | - | |
| Kimberly McCutcheon Jablonski | F | - | 2 years | |
| Sourav Kundu | M | 64 | 3 years | |
| Kyri van Hoose | M | - | 3 years | |
| David Mott | M | 58 |
XTuit Pharmaceuticals, Inc.
XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology XTuit Pharmaceuticals, Inc. develops drugs for the treatment of cancer. The firm develops pharmaceutical products for use in the diagnosis and treatment of oncological, tumor and inflammatory diseases. The company was founded by Alan L. Crane, Rakesh Kumar Jain, Andrew Werk Cook, Edwin L. Steele, David H. Koch, Ronald Evans, Howard Hughes and Robert S. Langer, Jr. in 2011 and is headquartered in Waltham, MA. | - |
| John Umstead | M | - | 6 years | |
| Brian Sun | M | 40 | 2 years | |
| Jaa Roberson | F | - | 3 years | |
| Mark Avagliano | M | 48 | 5 years | |
| Heather Adams | F | - | 4 years | |
| Jorge Conde | M | 47 |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | 5 years |
| Andrew Partridge | M | 55 | 4 years | |
| Sean Parker | M | 44 |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | 6 years |
| Andrew Perry | M | 51 | 3 years | |
| Deborah Dunsire | M | 61 |
XTuit Pharmaceuticals, Inc.
XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology XTuit Pharmaceuticals, Inc. develops drugs for the treatment of cancer. The firm develops pharmaceutical products for use in the diagnosis and treatment of oncological, tumor and inflammatory diseases. The company was founded by Alan L. Crane, Rakesh Kumar Jain, Andrew Werk Cook, Edwin L. Steele, David H. Koch, Ronald Evans, Howard Hughes and Robert S. Langer, Jr. in 2011 and is headquartered in Waltham, MA. | - |
| Andrew Beelen | M | - | - | |
| Patrick M. Gray | M | 75 |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Aron M. Knickerbocker | M | 54 | 10 years | |
| William Steere | M | 87 | 28 years | |
| Jing Rong Cui | M | 60 | 7 years | |
| William Ringo | M | 78 | 10 years | |
| Julie Grant | F | 41 | 5 years | |
| Lewis Williams | M | 74 | 18 years | |
| Jeffrey Kindler | M | 68 | 8 years | |
| Sheila Gujrathi | M | 53 | 6 years | |
| Jay C. Strum | M | - | 11 years | |
| Mark Velleca | M | 60 | 9 years | |
| R. Lee Douglas | M | 72 | 15 years | |
| Brian Baker | M | 57 | 4 years | |
| Seth A. Rudnick | M | 75 | 7 years | |
| Thomas Civik | M | 55 | 1 years | |
| Usman Azam | M | 55 |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | 6 years |
| Amy Schulman | F | 63 | 6 years | |
| Francis Sarena | M | 53 | 11 years | |
| Luis Borges | M | 62 | 5 years | |
| Briggs Morrison | M | 65 | 7 years | |
| Everett Cunningham | M | 57 | 9 years | |
| Paolo Tombesi | M | 60 | 1 years | |
| Yi Ning Zhao | M | 53 | 8 years | |
| Jacob Chacko | M | 45 | 3 years | |
| Jeff Macdonald | M | - | 3 years | |
| Martin Forrest | M | - | 2 years | |
| Kapil Dhingra | M | 64 | 6 years | |
| Marc Tessier-Lavigne | M | 64 | 4 years | |
| Soma Gupta | F | - | 7 years | |
| Simeon George | M | 46 | 5 years | |
| John Mascotte | M | 84 | 4 years | |
| David White | M | 59 | 2 years | |
| Mark Alles | M | 64 | 1 years | |
| Franklin Berger | M | 74 | 11 years | |
| Clarence Machado | M | 60 | 3 years | |
| Linda Rubinstein | F | 58 | - | |
| Willie Deese | M | 68 | 4 years | |
| Jonathan Graham | M | 63 | - | |
| Rakesh Kumar Jain | M | 74 |
XTuit Pharmaceuticals, Inc.
XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology XTuit Pharmaceuticals, Inc. develops drugs for the treatment of cancer. The firm develops pharmaceutical products for use in the diagnosis and treatment of oncological, tumor and inflammatory diseases. The company was founded by Alan L. Crane, Rakesh Kumar Jain, Andrew Werk Cook, Edwin L. Steele, David H. Koch, Ronald Evans, Howard Hughes and Robert S. Langer, Jr. in 2011 and is headquartered in Waltham, MA. | 6 years |
| Freda Lewis-Hall | M | 69 | 11 years | |
| Frances Fergusson | M | 79 | 9 years | |
| Robert Landry | M | 60 | 4 years | |
| M. Anthony Burns | M | 81 | 25 years | |
| Mark McDade | M | 69 | 12 years | |
| Peder K. Jensen | M | 69 | 10 years | |
| Carl Gordon | M | 59 | 3 years | |
| Annette C. North | F | 58 | 3 years | |
| Carol Schafer | F | 60 | 2 years | |
| Andrew Witty | M | 59 | 3 years | |
| Dana Hu-Lowe | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Garry Nicholson
- Personal Network